Stock Ideas
Stocks
Funds
Screener
Sectors
Watchlists
PSNL

PSNL - Personalis Inc Stock Price, Fair Value and News

2.89USD+0.05 (+1.76%)Delayed as of 25 Jul 2024, 02:12 pm ET

Market Summary

PSNL
USD2.89+0.05
Delayedas of 25 Jul 2024, 02:12 pm
1.76%

PSNL Stock Price

View Fullscreen

PSNL RSI Chart

PSNL Valuation

Market Cap

147.5M

Price/Earnings (Trailing)

-1.59

Price/Sales (Trailing)

1.99

EV/EBITDA

-1.28

Price/Free Cashflow

-2.16

PSNL Price/Sales (Trailing)

PSNL Profitability

Operating Margin

25.59%

EBT Margin

-124.79%

Return on Equity

-76.73%

Return on Assets

-47.42%

Free Cashflow Yield

-46.21%

PSNL Fundamentals

PSNL Revenue

Revenue (TTM)

74.1M

Rev. Growth (Yr)

3.53%

Rev. Growth (Qtr)

-0.76%

PSNL Earnings

Earnings (TTM)

-92.6M

Earnings Growth (Yr)

54.75%

Earnings Growth (Qtr)

51.22%

Breaking Down PSNL Revenue

52 Week Range

3.12
(Low)(High)

Last 7 days

25.8%

Last 30 days

130.1%

Last 90 days

126.4%

Trailing 12 Months

32.2%

How does PSNL drawdown profile look like?

PSNL Financial Health

Current Ratio

3.84

PSNL Investor Care

Shares Dilution (1Y)

11.02%

Diluted EPS (TTM)

-1.9

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202474.1M000
202368.7M67.1M70.5M73.5M
202279.8M76.4M69.0M65.0M
202180.4M82.5M85.0M85.5M
202070.3M74.0M76.6M78.6M
201947.7M54.7M60.2M65.2M
201816.5M23.6M30.7M37.8M
20170009.4M
PSNL
Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or plasma sample; ImmunoID Next for tumor profiling from tissue; NeXT Liquid Biopsy for tumor profiling from plasma; NeXT Personal, a liquid biopsy offering for personalized tumor tracking for patients; NeXT Dx Test, a genomic cancer profiling test to optimize therapy selection and match patients to clinical trials; and NeXT SHERPA and NeXT NEOPS for neoantigen prediction capabilities. The company also provides ACE platform for clinical and therapeutic applications, such as neoantigen prediction, biomarker identification, and novel drug target selection. It serves pharmaceutical, biopharmaceutical, diagnostic testing, and biotechnology companies; healthcare providers; universities; non-profits; and government entities. The company was incorporated in 2011 and is headquartered in Fremont, California.
 CEO
 WEBSITEpersonalis.com
 INDUSTRYDiagnostics & Research
 EMPLOYEES395

Personalis Inc Frequently Asked Questions


What is the ticker symbol for Personalis Inc? What does PSNL stand for in stocks?

PSNL is the stock ticker symbol of Personalis Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Personalis Inc (PSNL)?

As of Wed Jul 24 2024, market cap of Personalis Inc is 147.51 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of PSNL stock?

You can check PSNL's fair value in chart for subscribers.

Is Personalis Inc a good stock to buy?

The fair value guage provides a quick view whether PSNL is over valued or under valued. Whether Personalis Inc is cheap or expensive depends on the assumptions which impact Personalis Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for PSNL.

What is Personalis Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Jul 24 2024, PSNL's PE ratio (Price to Earnings) is -1.59 and Price to Sales (PS) ratio is 1.99. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. PSNL PE ratio will change depending on the future growth rate expectations of investors.